◆ 会议时间：2025年6月2-7日
◆ 会议地点：阿根廷 布宜诺斯艾利斯

◆ 会议简介：

2025年第63届粒子治疗协作组(PTCOG)年会将于2025年6月2-7日在阿根廷布宜诺斯艾利斯举行，PTCOG年会是粒子治疗领域首屈一指的聚焦前沿科学、技术 和临床应用的科学会议，预计将有超过1000名来自世界各地的专业人士与会，与会者包括医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员和行业专业人士等等。

国际粒子治疗协作委员会(PTCOG)成立于1985年，是一个由对质子、轻离子和重带电粒子放射治疗感兴超的科学家和专业人士组成的非营利性国际组织。PTCOG的使命是促进粒子治疗的科学、技术和实际临床应用，最终目标宣是最终目标是在放射疗法中尽可能提高癌症治疗水平。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

PTCOT 63- 63rd Annual Conference of the Particle Therapy Co-Operative Group

Dates:
2-7 June 2025

Venue:
Argentine Proton Therapy Center (CeArP)
Buenos Aires, Argentina

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

• View the Abstract Topics

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for oral or e-poster presentation.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
• An individual may be listed as the presenting author on one abstract only.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by 11 March 2025 will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Conference publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy:
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Conference. Abstracts containing updated information or modified data to previously published or presented abstracts will not be considered or accepted for presentation.
• Abstracts must be submitted in English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

​GUIDELINES FOR SUBMISSION

​Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  -Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Oral or E-Poster ​
• Abstract title – must be in sentence case and limited to 20 words. Please submit symbols as words.
• Abstract text – limited to 350 words including acknowledgements. Please note: word count is affected when tables are included.
• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format. You may upload up to 2 images / tables
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions  
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

Dear Colleagues,

On behalf of the PTCOG Executive Committee and the Local Organizing Committee, it is my great pleasure to invite you to Buenos Aires, Argentina, for the 63rd Annual Conference of the Particle Therapy Cooperative Group (PTCOG 63), taking place from 2-7 June 2025. This is a particularly special event as it marks the first time PTCOG organizes the Annual Conference in South America. It will be hosted in Argentina, and we are thrilled to be here during a pivotal moment for the region with the opening of Argentina’s first Proton Therapy Centre.

Buenos Aires, a vibrant city known for its rich culture, will serve as the perfect backdrop for our conference. As we gather to share the latest advancements and foster new collaborations in particle therapy, we hope this meeting will inspire and impact the growth of particle therapy in Latin America. We highly encourage the participation of colleagues from across Central and South America at PTCOG 63, where we will have dedicated sessions in Spanish, overcoming language barriers and promoting successful interaction between peers from the Latin American countries. This will provide an important opportunity for participants from the region to engage more deeply, access global knowledge, strengthen regional cooperation, and contribute to the broader exchange of expertise in particle therapy.

PTCOG 63 will begin with two days of educational sessions, followed by three days of multi-session scientific presentations and discussions, featuring topics across clinics, physics, and biology. Our theme, “Bridging Borders in Particle Therapy,” emphasizes the importance of expanding access and collaboration in our field, especially for developing countries. We anticipate a robust scientific program filled with plenary talks, round tables, and active involvement from our 16 Sub-Committees, including our growing Scholar-in-Training (SIT) Sub-Committee, which continues to encourage the participation of younger generations in PTCOG leadership.

As PTCOG continues to expand, now with over 4,000 members and more than 100 facilities represented in our Steering Committee, we look forward to exploring new avenues of research, including discussions on funding for small research projects and updates on the International Journal of Particle Therapy.

We look forward to your participation in PTCOG 63 and to creating unforgettable memories in Buenos Aires. This will not only be an exceptional scientific experience but also an opportunity to immerse yourself in the unique spirit and hospitality of Argentina.

We can’t wait to welcome you to Buenos Aires!

Marco Durante
PTCOG President

Martin Jermann
PTCOG Secretary

Gustavo A. Santa Cruz
Local Organizing Committee (LOC)

注册费：

Registration fees (in USD):

Fees apply to payments received prior to the indicated deadlines.

* The discounted registration fees applicable to Radiation Therapists, Dosimetrists and Students are only available to those providing valid credentials requested via the registration form. The standard registration fee will apply to anyone unable to prove one of these three positions when requested.
** In order to benefit from this rate, please upload a copy of your passport. 

Registration Fees Include:

Educational Sessions Categories (2-3 June):

• All Educational Sessions included in the final program.
• Complimentary access to the Educational Sessions Welcome Reception
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration.

Scientific Meeting Categories (4-6 June):

• All Scientific Meeting Sessions as included in the final program.
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception (on June 3rd, afternoon).
• Access to PTCOG 63 Exhibition and poster area
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration.

All Session Categories Include (2-6 June):

• All content as per final program
• Complimentary access to the Educational Sessions Welcome Reception
• Complimentary access to the Exhibition Opening and Scientific Meeting Welcome Reception
• Access to PTCOG 63 Exhibition and poster area
• Refreshments during coffee breaks as indicated in the program.
• Conference materials provided via registration

◆ 参会对象：医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员以及从事该领域研究的科学家、研究人员、企业代表等等。